Sofopoulos, Michael
Fortis, Sotirios P.
Vaxevanis, Christoforos K.
Sotiriadou, Nectaria N.
Arnogiannaki, Niki
Ardavanis, Alexandros
Vlachodimitropoulos, Dimitrios
Perez, Sonia A.
Baxevanis, Constantin N.
Article History
Received: 29 May 2019
Accepted: 29 September 2019
First Online: 9 October 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: The study was approved by the Institutional Review Board of Saint Savas Cancer Hospital, Study code: IRB-ID 6079/448/10-6-13. Date of approval: 10/06/2013; retrospective study (2000–2010); first patient prospectively enrolled: 14/2/2014.
: Retrospectively analyzed (2000–2010) and prospectively enrolled patients (2014–2015) who signed the same informed consent. Individual participants provided written informed consent for the use of their specimens. In cases where retrospectively analyzed patients could not visit the hospital to provide signed informed consent, they were informed orally via telephone calls by their oncologists. Clinical data were obtained from all patients anonymously. Patients were assured that confidentiality of their records will be protected according to the Greek regulations and laws.